Jul 8, 2011 | Michigan Lawyers Weekly
TAGS: Alyson Oliver , FDA , Jason J. Thompson , Mark Bernstein , MCL 600.2946 , psoriasis , Raptiva , Robert B. Sickels , Shay Blair v. Genetech Inc.
Actinobac Biomed, Inc. Demonstrates In Vivo Efficacy for Psoriasis Treatment
For some, it is just a nuisance. For others, it is disabling. On a continuing quest to find more effective treatment for psoriasis sufferers, an article published in the Journal of Investigative Dermatology reported that the latest data from experiments performed by Actinobac Biomed, Inc., with financial backing from Foundation Venture Capital ...
"XOMA Ltd. (XOMAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Published
Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Xoma Ltd. is a biopharmaceutical company engaged in the discovery, development and manufacture of therapeutic antibodies for the treatment of inflammatory, autoimmune, infectious and oncological diseases.
Also on Topix